Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen quietly whisks away its $544M autoimmune rival to Celgene
Biogen quietly whisks away its $544M autoimmune rival to Celgene
Biogen quietly whisks away its $544M autoimmune rival to Celgene
Submitted by
admin
on October 26, 2016 - 9:28am
Source:
Endpoints
News Tags:
Biogen
Celgene
autoimmune disease
amiselimod
ozanimod
Headline:
Biogen quietly whisks away its $544M autoimmune rival to Celgene
Do Not Allow Advertisers to Use My Personal information
